These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 9576105)

  • 41. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
    Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M
    Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes.
    Mika D; Bobin P; Pomérance M; Lechêne P; Westenbroek RE; Catterall WA; Vandecasteele G; Leroy J; Fischmeister R
    Cardiovasc Res; 2013 Nov; 100(2):336-46. PubMed ID: 23933582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse.
    Cherry JA; Thompson BE; Pho V
    Biochim Biophys Acta; 2001 Mar; 1518(1-2):27-35. PubMed ID: 11267656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans.
    Adderley SP; Dufaux EA; Sridharan M; Bowles EA; Hanson MS; Stephenson AH; Ellsworth ML; Sprague RS
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1617-24. PubMed ID: 19252089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
    Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
    Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
    Yu SM; Cheng ZJ; Kuo SC
    Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Control of renin secretion from rat juxtaglomerular cells by cAMP-specific phosphodiesterases.
    Friis UG; Jensen BL; Sethi S; Andreasen D; Hansen PB; Skøtt O
    Circ Res; 2002 May; 90(9):996-1003. PubMed ID: 12016266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.
    Liu H; Maurice DH
    Br J Pharmacol; 1998 Dec; 125(7):1501-10. PubMed ID: 9884079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes.
    Ekholm D; Mulloy JC; Gao G; Degerman E; Franchini G; Manganiello VC
    Biochem Pharmacol; 1999 Sep; 58(6):935-50. PubMed ID: 10509746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.
    Yao M; Roberts DD; Isenberg JS
    Pharmacol Res; 2011 Jan; 63(1):13-22. PubMed ID: 20971192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
    Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
    Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphodiesterase 3 activity is reduced in dog lung following pacing-induced heart failure.
    Tarpey SB; Sawmiller DR; Kelly C; Thompson WJ; Townsley MI
    Am J Physiol Lung Cell Mol Physiol; 2003 May; 284(5):L766-73. PubMed ID: 12676767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells.
    Yao J; Hiramatsu N; Zhu Y; Morioka T; Takeda M; Oite T; Kitamura M
    J Am Soc Nephrol; 2005 Jan; 16(1):58-67. PubMed ID: 15537869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of phosphodiesterase has an additive effect on estrogen's ability to inhibit collagen synthesis in vascular smooth muscle cells.
    Dimopoulos GJ; Langner RO
    Vascul Pharmacol; 2009; 50(1-2):78-82. PubMed ID: 19007913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of phosphodiesterase PDE-3/PDE-4-specific inhibitors on vasoconstriction and cAMP-dependent vasorelaxation following balloon angioplasty.
    Zhao H; Quilley J; Montrose DC; Rajagopalan S; Guan Q; Smith CJ
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2973-81. PubMed ID: 17293498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of a cGMP-stimulated cAMP phosphodiesterase by protein kinase C in a liver Golgi-endosomal fraction.
    Geoffroy V; Fouque F; Nivet V; Clot JP; Lugnier C; Desbuquois B; Benelli C
    Eur J Biochem; 1999 Feb; 259(3):892-900. PubMed ID: 10092879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.